MARCELLA ROWLEY: Open Payments
NPI 1740301837 · RIVERTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,805 in 155 payments from 29 companies in 2025. Trend: 2023 $2,397 · 2024 $2,917 · 2025 $3,805
Food & beverage: $3,318Consulting: $350Education: $137
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $481 |
| JAZZ PHARMACEUTICALS INC. | 6 | $470 |
| Amgen Inc. | 23 | $386 |
| Axsome Therapeutics, Inc. | 12 | $344 |
| Avadel CNS Pharmaceuticals, LLC | 6 | $330 |
| Otsuka America Pharmaceutical, Inc. | 18 | $318 |
| ABBVIE INC. | 22 | $270 |
| Corcept Therapeutics | 8 | $189 |
| Merck Sharp & Dohme LLC | 8 | $188 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $107 |
Products named: XYWAV, REXULTI, LUMRYZ, BREZTRI, OTEZLA, Korlym, REPATHA, Sunosi.
Industry payments across UT — which companies pay providers there.
